Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:alpha-D-galactose
go back to main search page
Accession:CHEBI:28061 term browser browse the term
Definition:D-Galactopyranose having alpha-configuration at the anomeric centre.
Synonyms:exact_synonym: alpha-D-galactopyranose
 related_synonym: Formula=C6H12O6;   Gal-alpha;   InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6+/m1/s1;   InChIKey=WQZGKKKJIJFFOK-PHYPRBDBSA-N;   SMILES=OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O;   WURCS=2.0/1,1,0/[a2112h-1a_1-5]/1/;   alpha-D-Gal
 alt_id: CHEBI:10231;   CHEBI:22373;   CHEBI:42741
 xref: CAS:26566-61-0;   CAS:3646-73-9;   CAS:59-23-4;   Drug_Central:1271;   GlyGen:G09546QO;   GlyTouCan:G09546QO;   Gmelin:648638;   KEGG:C00984;   KEGG:C01582;   KEGG:D04291;   KNApSAcK:C00001119
 xref_mesh: MESH:D005690
 xref: PDBeChem:GLA;   PMID:17991151;   PMID:19443021;   PMID:25568069;   PMID:31537530;   PMID:7521740;   PMID:8154046;   Reaxys:1281609
 cyclic_relationship: is_enantiomer_of CHEBI:42905


show annotations for term's descendants           Sort by:
alpha-D-galactose term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase increases activity
multiple interactions 		ISO Galactose results in increased activity of ACHE protein
catalpol inhibits the reaction [Galactose results in increased activity of ACHE protein]; theaflavin-3,3'-digallate inhibits the reaction [Galactose results in increased activity of ACHE protein] 		CTD PMID:23612000 PMID:36638877 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410 		JBrowse link
G Ager advanced glycosylation end product-specific receptor increases expression
decreases expression
multiple interactions 		ISO
EXP 		Galactose results in increased expression of AGER mRNA; Galactose results in increased expression of AGER protein
Galactose results in decreased expression of AGER protein
[Ethanol co-treated with Galactose] results in decreased expression of AGER protein
agomelatine inhibits the reaction [Galactose results in increased expression of AGER protein] 		CTD PMID:22687555 PMID:33516661 PMID:34673010 NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685 		JBrowse link
G Aif1 allograft inflammatory factor 1 increases expression
multiple interactions 		ISO
EXP 		Galactose results in increased expression of AIF1 protein
lycopene inhibits the reaction [Galactose results in increased expression of AIF1 protein]
agomelatine inhibits the reaction [Galactose results in increased expression of AIF1 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of AIF1 protein] 		CTD PMID:28974442 PMID:34673010 NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 multiple interactions
increases expression 		ISO protocatechuic acid inhibits the reaction [Galactose results in increased expression of AKR1B1 mRNA] CTD PMID:22687555 NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315 		JBrowse link
G Aox1 aldehyde oxidase 1 increases expression
multiple interactions 		ISO Galactose results in increased expression of AOX1 mRNA
sodium bisulfide inhibits the reaction [Galactose results in increased expression of AOX1 mRNA] 		CTD PMID:23274001 NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:67,073,821...67,152,980 		JBrowse link
G App amyloid beta precursor protein multiple interactions ISO [Galactose co-treated with Aluminum Chloride] results in decreased expression of APP protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of APP protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of APP protein] CTD PMID:35537655 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971 		JBrowse link
G Aqp4 aquaporin 4 multiple interactions ISO [Ethanol co-treated with Galactose] results in decreased expression of AQP4 protein CTD PMID:33516661 NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098 		JBrowse link
G Atf4 activating transcription factor 4 multiple interactions ISO [Galactose co-treated with Glucose deficiency] promotes the reaction [leflunomide results in increased expression of ATF4 protein] CTD PMID:29427785 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Atg5 autophagy related 5 decreases expression
multiple interactions 		EXP Galactose results in decreased expression of ATG5 mRNA
candesartan inhibits the reaction [Galactose results in decreased expression of ATG5 mRNA] 		CTD PMID:34906534 NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821 		JBrowse link
G Atg7 autophagy related 7 decreases expression
multiple interactions 		EXP
ISO 		Galactose results in decreased expression of ATG7 protein
MIR34A mRNA promotes the reaction [Galactose results in decreased expression of ATG7 protein] 		CTD PMID:28302704 NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:149,391,390...149,598,319 		JBrowse link
G Atox1 antioxidant 1 copper chaperone decreases expression
multiple interactions 		ISO Galactose results in decreased expression of ATOX1 mRNA
sodium bisulfide inhibits the reaction [Galactose results in decreased expression of ATOX1 mRNA] 		CTD PMID:23274001 NCBI chr10:40,065,525...40,080,627
Ensembl chr10:40,065,527...40,080,585 		JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
increases expression 		ISO
EXP 		Phycocyanin inhibits the reaction [Galactose results in increased expression of BAX protein]
Galactose results in increased expression of BAX mRNA; Galactose results in increased expression of BAX protein
agomelatine inhibits the reaction [Galactose results in increased expression of BAX protein]; Finasteride inhibits the reaction [Galactose results in increased expression of BAX protein]; Galactose promotes the reaction [sodium arsenite results in increased expression of BAX mRNA]; Melatonin inhibits the reaction [Galactose results in increased expression of BAX protein]; Saponins inhibits the reaction [Galactose results in increased expression of BAX protein]
torularhodin inhibits the reaction [Galactose results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Galactose results in increased expression of BAX protein] 		CTD PMID:23036742 PMID:25892055 PMID:31431007 PMID:34673010 PMID:35259467 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
decreases expression 		ISO
EXP 		Phycocyanin inhibits the reaction [Galactose results in decreased expression of BCL2 protein]
agomelatine inhibits the reaction [Galactose results in decreased expression of BCL2 protein]; Galactose promotes the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]; Melatonin inhibits the reaction [Galactose results in decreased expression of BCL2 protein]; Saponins inhibits the reaction [Galactose results in decreased expression of BCL2 protein]
Galactose results in decreased expression of BCL2 mRNA; Galactose results in decreased expression of BCL2 protein 		CTD PMID:23036742 PMID:25892055 PMID:34673010 PMID:35259467 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bdnf brain-derived neurotrophic factor decreases expression
multiple interactions 		ISO Galactose results in decreased expression of BDNF mRNA; Galactose results in decreased expression of BDNF protein
lycopene inhibits the reaction [Galactose results in decreased expression of BDNF mRNA]; lycopene inhibits the reaction [Galactose results in decreased expression of BDNF protein] 		CTD PMID:28974442 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Becn1 beclin 1 multiple interactions
decreases expression 		EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in decreased expression of BECN1 protein]; candesartan inhibits the reaction [Galactose results in decreased expression of BECN1 mRNA]
Galactose results in decreased expression of BECN1 mRNA; Galactose results in decreased expression of BECN1 protein 		CTD PMID:25997894 PMID:28302704 PMID:34906534 NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Casp12 caspase 12 multiple interactions
increases expression 		EXP agomelatine inhibits the reaction [Galactose results in increased expression of CASP12 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of CASP12 protein] CTD PMID:34673010 NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442 		JBrowse link
G Casp3 caspase 3 increases cleavage
multiple interactions
increases activity
increases expression 		ISO
EXP 		Galactose results in increased cleavage of CASP3 protein
Phycocyanin inhibits the reaction [Galactose results in increased cleavage of CASP3 protein]
Galactose results in increased activity of CASP3 protein
albicanol inhibits the reaction [Galactose results in increased expression of CASP3 mRNA]; Pioglitazone inhibits the reaction [Galactose results in increased activity of CASP3 protein]
[Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of CASP3 protein] 		CTD PMID:23036742 PMID:23795773 PMID:25997894 PMID:32295448 PMID:33761044 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp9 caspase 9 multiple interactions
increases expression 		EXP
ISO 		[Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]
Galactose results in increased expression of CASP9 protein
albicanol inhibits the reaction [Galactose results in increased expression of CASP9 mRNA] 		CTD PMID:25997894 PMID:32295448 PMID:33761044 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cat catalase increases activity
multiple interactions
decreases activity
affects activity 		EXP
ISO 		Galactose results in increased activity of CAT protein
[Galactose co-treated with Finasteride] results in increased expression of CAT mRNA; candesartan inhibits the reaction [Galactose results in decreased activity of CAT protein]; Quercetin inhibits the reaction [Galactose results in increased activity of CAT protein]
[Galactose co-treated with Aluminum Chloride] results in decreased expression of CAT protein; albicanol inhibits the reaction [Galactose results in decreased activity of CAT protein]; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of CAT protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of CAT protein]; torularhodin inhibits the reaction [Galactose results in decreased activity of CAT protein]
Galactose affects the activity of CAT protein 		CTD PMID:17211565 PMID:31431007 PMID:32295448 PMID:33761044 PMID:34906534 More... NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Ccn1 cellular communication network factor 1 multiple interactions ISO [Galactose co-treated with Fenofibrate] results in increased expression of CCN1 protein CTD PMID:39442682 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 increases expression
multiple interactions 		EXP Galactose results in increased expression of CCN2 protein
Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of CCN2 protein] 		CTD PMID:30367734 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Cdh5 cadherin 5 multiple interactions
decreases expression 		ISO Ethanol promotes the reaction [Galactose results in decreased expression of CDH5 protein] CTD PMID:33516661 NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822 		JBrowse link
G Cdk5r1 cyclin-dependent kinase 5 regulatory subunit 1 increases expression
multiple interactions 		ISO Galactose results in increased expression of CDK5R1 protein
gentiopicroside analog inhibits the reaction [Galactose results in increased expression of CDK5R1 protein] 		CTD PMID:36878094 NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A multiple interactions
increases expression 		EXP
ISO 		agomelatine inhibits the reaction [Galactose results in increased expression of CDKN2A protein]; Melatonin inhibits the reaction [Galactose results in increased expression of CDKN2A protein]
(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of CDKN2A protein]; Chloroquine inhibits the reaction [(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of CDKN2A protein]] 		CTD PMID:34673010 PMID:36792013 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Chat choline O-acetyltransferase multiple interactions
decreases activity 		ISO catalpol inhibits the reaction [Galactose results in decreased activity of CHAT protein] CTD PMID:23612000 NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,663,665...7,723,416 		JBrowse link
G Chrm1 cholinergic receptor, muscarinic 1 multiple interactions
decreases expression 		ISO catalpol inhibits the reaction [Galactose results in decreased expression of CHRM1 protein] CTD PMID:23612000 NCBI chr 1:214,996,180...215,012,136
Ensembl chr 1:214,995,872...215,020,602 		JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions
decreases expression 		ISO gentiopicroside analog inhibits the reaction [Galactose results in decreased expression of CTNNB1 protein] CTD PMID:36878094 NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Cybb cytochrome b-245 beta chain increases expression
multiple interactions 		EXP Galactose results in increased expression of CYBB protein
agomelatine inhibits the reaction [Galactose results in increased expression of CYBB protein]; Melatonin inhibits the reaction [Galactose results in increased expression of CYBB protein] 		CTD PMID:34673010 NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:16,030,596...16,065,065 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions
increases expression 		ISO
EXP 		[Galactose co-treated with Glucose deficiency] promotes the reaction [leflunomide results in increased expression of DDIT3 protein]; Phycocyanin inhibits the reaction [Galactose results in increased expression of DDIT3 protein]
agomelatine inhibits the reaction [Galactose results in increased expression of DDIT3 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of DDIT3 protein] 		CTD PMID:23036742 PMID:29427785 PMID:34673010 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Dnm1l dynamin 1-like increases expression
multiple interactions 		ISO
EXP 		Galactose results in increased expression of DNM1L protein
MIR34A mRNA promotes the reaction [Galactose results in increased expression of DNM1L protein] 		CTD PMID:28302704 NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
increases phosphorylation 		EXP agomelatine inhibits the reaction [Galactose results in increased phosphorylation of EIF2AK3 protein]; Melatonin inhibits the reaction [Galactose results in increased phosphorylation of EIF2AK3 protein] CTD PMID:34673010 NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 increases phosphorylation
multiple interactions 		EXP Galactose results in increased phosphorylation of ERN1 protein
agomelatine inhibits the reaction [Galactose results in increased phosphorylation of ERN1 protein] 		CTD PMID:34673010 NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791 		JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions
increases expression 		EXP Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of FGF2 protein] CTD PMID:30367734 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493 		JBrowse link
G Galk1 galactokinase 1 multiple interactions
increases metabolic processing 		ISO [GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate CTD PMID:20696150 NCBI chr10:101,742,067...101,746,244
Ensembl chr10:101,735,061...101,746,258 		JBrowse link
G Gap43 growth associated protein 43 decreases expression
multiple interactions 		ISO Galactose results in decreased expression of GAP43 mRNA
Quercetin inhibits the reaction [Galactose results in decreased expression of GAP43 mRNA] 		CTD PMID:16707173 NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit decreases expression
multiple interactions 		EXP Galactose results in decreased expression of GCLC mRNA
Saponins inhibits the reaction [Galactose results in decreased expression of GCLC mRNA] 		CTD PMID:25892055 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gdnf glial cell derived neurotrophic factor multiple interactions
decreases expression 		EXP candesartan inhibits the reaction [Galactose results in decreased expression of GDNF mRNA] CTD PMID:34906534 NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240 		JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions
increases expression 		EXP agomelatine inhibits the reaction [Galactose results in increased expression of GFAP protein]; Melatonin inhibits the reaction [Galactose results in increased expression of GFAP protein] CTD PMID:34673010 NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685 		JBrowse link
G Glb1 galactosidase, beta 1 increases expression
multiple interactions 		ISO Galactose results in increased expression of GLB1 protein
(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of GLB1 protein]; Chloroquine inhibits the reaction [(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of GLB1 protein]] 		CTD PMID:36792013 NCBI chr 8:122,963,718...123,036,326
Ensembl chr 8:122,963,718...123,036,326 		JBrowse link
G Glo1 glyoxalase 1 multiple interactions ISO Galactose results in decreased expression of and results in decreased activity of GLO1 protein; protocatechuic acid inhibits the reaction [Galactose results in decreased expression of and results in decreased activity of GLO1 protein] CTD PMID:22687555 NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,665,061...8,683,191 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions ISO [Lipopolysaccharides co-treated with Galactose] results in increased expression of GPT protein; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of GPT protein] CTD PMID:34416243 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160 		JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions
decreases expression 		ISO theaflavin-3,3'-digallate inhibits the reaction [Galactose results in decreased expression of GPX1 mRNA] CTD PMID:36638877 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Gpx4 glutathione peroxidase 4 multiple interactions EXP [Galactose co-treated with Finasteride] results in increased expression of GPX4 protein CTD PMID:39265715 NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629 		JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 increases expression
multiple interactions 		EXP Galactose results in increased expression of GRIN1 protein
agomelatine inhibits the reaction [Galactose results in increased expression of GRIN1 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of GRIN1 protein] 		CTD PMID:34673010 NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754 		JBrowse link
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B increases expression
multiple interactions 		EXP Galactose results in increased expression of GRIN2B protein
agomelatine inhibits the reaction [Galactose results in increased expression of GRIN2B protein]; Melatonin inhibits the reaction [Galactose results in increased expression of GRIN2B protein] 		CTD PMID:34673010 NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions ISO Galactose results in increased expression of and results in decreased phosphorylation of GSK3B protein; gentiopicroside analog inhibits the reaction [Galactose results in increased expression of and results in decreased phosphorylation of GSK3B protein] CTD PMID:36878094 NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G Gss glutathione synthetase multiple interactions
decreases expression 		ISO sodium bisulfide inhibits the reaction [Galactose results in decreased expression of GSS mRNA] CTD PMID:23274001 NCBI chr 3:164,508,005...164,538,343
Ensembl chr 3:164,508,005...164,538,306 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 multiple interactions ISO [Galactose co-treated with Aluminum Chloride] results in increased expression of HES1 protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of HES1 protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of HES1 protein] CTD PMID:35537655 NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions ISO Galactose affects the reaction [Fusaric Acid affects the expression of HIF1A protein] CTD PMID:31654802 NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
decreases expression 		EXP
ISO 		Saponins inhibits the reaction [Galactose results in decreased expression of HMOX1 mRNA]
albicanol inhibits the reaction [Galactose results in decreased expression of HMOX1 protein]; Lycopene inhibits the reaction [Galactose results in decreased expression of HMOX1 mRNA]; torularhodin inhibits the reaction [Galactose results in decreased expression of HMOX1 mRNA]; torularhodin inhibits the reaction [Galactose results in decreased expression of HMOX1 protein]; Vitamin E inhibits the reaction [Galactose results in decreased expression of HMOX1 mRNA]; Vitamin E inhibits the reaction [Galactose results in decreased expression of HMOX1 protein]
Galactose results in decreased expression of HMOX1 mRNA; Galactose results in decreased expression of HMOX1 protein 		CTD PMID:25892055 PMID:28974442 PMID:31431007 PMID:33761044 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hsf1 heat shock transcription factor 1 increases activity ISO Galactose results in increased activity of HSF1 protein CTD PMID:34170685 NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions
increases expression 		ISO
EXP 		Phycocyanin inhibits the reaction [Galactose results in increased expression of HSPA5 protein]
Melatonin inhibits the reaction [Galactose results in increased expression of HSPA5 protein] 		CTD PMID:23036742 PMID:34673010 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790 		JBrowse link
G Ifnb1 interferon beta 1 multiple interactions ISO [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] results in increased expression of IFNB1 protein; scoparone inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] results in increased expression of IFNB1 protein] CTD PMID:23535186 NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487 		JBrowse link
G Il10 interleukin 10 multiple interactions ISO [Galactose co-treated with Aluminum Chloride] results in decreased expression of IL10 protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of IL10 protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in decreased expression of IL10 protein] CTD PMID:35537655 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il1b interleukin 1 beta increases expression
increases secretion
multiple interactions 		ISO
EXP 		Galactose results in increased expression of IL1B mRNA; Galactose results in increased expression of IL1B protein
Galactose results in increased secretion of IL1B protein
[Galactose co-treated with Aluminum Chloride] results in increased expression of IL1B protein; albicanol inhibits the reaction [Galactose results in increased expression of IL1B mRNA]; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL1B protein]; catalpol inhibits the reaction [Galactose results in increased expression of IL1B protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL1B protein]; Lycopene inhibits the reaction [Galactose results in increased expression of IL1B protein]; protocatechuic acid inhibits the reaction [Galactose results in increased secretion of IL1B protein]; torularhodin inhibits the reaction [Galactose results in increased secretion of IL1B protein]
[Galactose co-treated with Aluminum Chloride] results in increased expression of IL1B protein; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL1B protein] 		CTD PMID:22687555 PMID:23612000 PMID:28974442 PMID:29405769 PMID:31431007 More... NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il6 interleukin 6 multiple interactions
increases secretion
increases expression 		ISO
EXP 		[Galactose co-treated with Aluminum Chloride] results in increased expression of IL6 protein; [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL6 protein; [Lipopolysaccharides co-treated with Galactose] results in increased expression of IL6 protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL6 protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IL6 protein]; protocatechuic acid inhibits the reaction [Galactose results in increased secretion of IL6 protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of IL6 protein]; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL6 protein]; torularhodin inhibits the reaction [Galactose results in increased secretion of IL6 protein]
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside compound K inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside F1 inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside Rg3 inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside Rh1 inhibits the reaction [Galactose results in increased secretion of IL6 protein]; ginsenoside Rh2 inhibits the reaction [Galactose results in increased secretion of IL6 protein]
Galactose results in increased expression of IL6 mRNA; Galactose results in increased expression of IL6 protein
Galactose promotes the reaction [sodium arsenite results in increased expression of IL6 mRNA] 		CTD PMID:22687555 PMID:23535186 PMID:29412148 PMID:31431007 PMID:32295448 More... NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Ins1 insulin 1 increases expression EXP Galactose results in increased expression of INS1 protein CTD PMID:39265715 NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682 		JBrowse link
G Irf3 interferon regulatory factor 3 multiple interactions ISO
EXP 		[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] results in increased phosphorylation of IRF3 protein; scoparone inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] results in increased phosphorylation of IRF3 protein]
[Galactose co-treated with Aluminum Chloride] results in increased expression of IRF3 mRNA; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of IRF3 mRNA] 		CTD PMID:23535186 PMID:29405769 NCBI chr 1:104,616,608...104,621,402
Ensembl chr 1:104,616,469...104,621,401 		JBrowse link
G Itpr3 inositol 1,4,5-trisphosphate receptor, type 3 multiple interactions
increases expression 		EXP agomelatine inhibits the reaction [Galactose results in increased expression of ITPR3 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of ITPR3 protein] CTD PMID:34673010 NCBI chr20:5,138,553...5,204,189
Ensembl chr20:5,118,834...5,204,184 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Galactose] affects the localization of and results in increased expression of JUN protein modified form; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] affects the localization of and results in increased expression of JUN protein modified form] CTD PMID:23535186 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 increases expression
multiple interactions 		ISO Galactose results in increased expression of KEAP1 mRNA; Galactose results in increased expression of KEAP1 protein
albicanol inhibits the reaction [Galactose results in increased expression of KEAP1 mRNA]; albicanol inhibits the reaction [Galactose results in increased expression of KEAP1 protein] 		CTD PMID:33761044 NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042 		JBrowse link
G Lct lactase increases hydrolysis EXP LCT protein results in increased hydrolysis of Galactose CTD PMID:14701853 NCBI chr13:42,334,347...42,376,872
Ensembl chr13:42,334,347...42,376,872 		JBrowse link
G Lrp1 LDL receptor related protein 1 multiple interactions
decreases expression 		ISO [Ethanol co-treated with Galactose] results in decreased expression of LRP1 protein
Galactose results in decreased expression of LRP1 protein 		CTD PMID:33516661 NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:65,265,639...65,346,196 		JBrowse link
G Lrp6 LDL receptor related protein 6 multiple interactions ISO [Galactose co-treated with gentiopicroside analog] results in increased expression of LRP6 protein CTD PMID:36878094 NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:169,000,968...169,131,716 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases phosphorylation
multiple interactions 		EXP Galactose results in increased phosphorylation of MAPK1 protein
Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased phosphorylation of MAPK1 protein] 		CTD PMID:30367734 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases phosphorylation
multiple interactions 		EXP Galactose results in increased phosphorylation of MAPK3 protein
Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased phosphorylation of MAPK3 protein] 		CTD PMID:30367734 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions
increases expression 		EXP Galactose promotes the reaction [sodium arsenite results in increased expression of MAPK8 mRNA]
Galactose results in increased expression of MAPK8 mRNA 		CTD PMID:35259467 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427 		JBrowse link
G Mapt microtubule-associated protein tau increases expression
multiple interactions 		ISO Galactose results in increased expression of MAPT protein
gentiopicroside analog inhibits the reaction [Galactose results in increased expression of MAPT protein] 		CTD PMID:36878094 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108 		JBrowse link
G Mfn2 mitofusin 2 increases expression
multiple interactions 		EXP
ISO 		Galactose results in increased expression of MFN2 protein
MIR34A mRNA promotes the reaction [Galactose results in increased expression of MFN2 protein] 		CTD PMID:28302704 NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495 		JBrowse link
G Mir34a microRNA 34a increases expression
multiple interactions 		EXP
ISO 		Galactose results in increased expression of MIR34A mRNA
MIR34A mRNA promotes the reaction [Galactose results in decreased expression of ATG7 protein]; MIR34A mRNA promotes the reaction [Galactose results in increased expression of DNM1L protein]; MIR34A mRNA promotes the reaction [Galactose results in increased expression of MFN2 protein]; MIR34A mRNA promotes the reaction [Galactose results in increased expression of SQSTM1 protein] 		CTD PMID:28302704 NCBI chr 5:165,815,952...165,816,053
Ensembl chr 5:165,815,952...165,816,053 		JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions
increases activity 		EXP Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased activity of MMP2 protein] CTD PMID:30367734 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions
decreases expression 		EXP agomelatine inhibits the reaction [Galactose results in decreased expression of MMP9 protein]; Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of and results in increased activity of MMP9 protein]; Galactose results in increased expression of and results in increased activity of MMP9 protein; Melatonin inhibits the reaction [Galactose results in decreased expression of MMP9 protein] CTD PMID:30367734 PMID:34673010 NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mt-co1 mitochondrially encoded cytochrome c oxidase I multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of COX1 protein CTD PMID:25997894 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,309...6,853 		JBrowse link
G Mt-nd4 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 affects metabolic processing ISO ND4 protein affects the metabolism of Galactose CTD PMID:8662757 NCBI chr MT:10,160...11,537
Ensembl chr MT:10,145...11,522 		JBrowse link
G Mt-nd6 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 affects metabolic processing ISO ND6 protein affects the metabolism of Galactose CTD PMID:9707444 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,531...14,049 		JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor multiple interactions ISO
EXP 		[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of MYD88 protein; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of MYD88 protein]
[Galactose co-treated with Aluminum Chloride] results in increased expression of MYD88 mRNA; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of MYD88 mRNA] 		CTD PMID:23535186 PMID:29405769 NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230 		JBrowse link
G Ndufb8 NADH:ubiquinone oxidoreductase subunit B8 multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of NDUFB8 protein CTD PMID:25997894 NCBI chr 1:253,357,878...253,362,936
Ensembl chr 1:253,357,841...253,362,936 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 affects localization
multiple interactions
decreases expression 		EXP
ISO 		Galactose affects the localization of NFE2L2 protein
albicanol inhibits the reaction [Galactose results in decreased expression of NFE2L2 mRNA]; albicanol inhibits the reaction [Galactose results in decreased expression of NFE2L2 protein]; theaflavin-3,3'-digallate inhibits the reaction [Galactose results in decreased expression of NFE2L2 mRNA]; torularhodin inhibits the reaction [Galactose results in decreased expression of NFE2L2 mRNA]; torularhodin inhibits the reaction [Galactose results in decreased expression of NFE2L2 protein]; Vitamin E inhibits the reaction [Galactose results in decreased expression of NFE2L2 mRNA]; Vitamin E inhibits the reaction [Galactose results in decreased expression of NFE2L2 protein]
Galactose results in decreased expression of NFE2L2 mRNA; Galactose results in decreased expression of NFE2L2 protein
Saponins inhibits the reaction [Galactose affects the localization of NFE2L2 protein] 		CTD PMID:25892055 PMID:31431007 PMID:33761044 PMID:36638877 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 increases expression
multiple interactions 		ISO
EXP 		Galactose results in increased expression of NFKB1 mRNA; Galactose results in increased expression of NFKB1 protein
Galactose promotes the reaction [sodium arsenite results in increased expression of NFKB1 mRNA] 		CTD PMID:22687555 PMID:35259467 NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
increases activity
increases expression 		ISO Oligopeptides inhibits the reaction [Galactose results in increased activity of NOS2 protein]
Galactose results in increased expression of NOS2 mRNA 		CTD PMID:23796539 PMID:28974442 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Notch1 notch receptor 1 multiple interactions ISO [Galactose co-treated with Aluminum Chloride] results in increased expression of NOTCH1 protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of NOTCH1 protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of NOTCH1 protein] CTD PMID:35537655 NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613 		JBrowse link
G Nox4 NADPH oxidase 4 increases expression
multiple interactions 		EXP Galactose results in increased expression of NOX4 protein
agomelatine inhibits the reaction [Galactose results in increased expression of NOX4 protein]; Melatonin inhibits the reaction [Galactose results in increased expression of NOX4 protein] 		CTD PMID:34673010 NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions
decreases expression 		EXP
ISO 		Saponins inhibits the reaction [Galactose results in decreased expression of NQO1 mRNA]
albicanol inhibits the reaction [Galactose results in decreased expression of NQO1 protein]; Lycopene inhibits the reaction [Galactose results in decreased expression of NQO1 mRNA]; torularhodin inhibits the reaction [Galactose results in decreased expression of NQO1 mRNA]; Vitamin E inhibits the reaction [Galactose results in decreased expression of NQO1 mRNA] 		CTD PMID:25892055 PMID:28974442 PMID:31431007 PMID:33761044 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Oat ornithine aminotransferase multiple interactions EXP Galactose inhibits the reaction [Cyclic AMP results in increased activity of OAT protein] CTD PMID:2827574 NCBI chr 1:196,777,973...196,797,754
Ensembl chr 1:196,777,975...196,797,754 		JBrowse link
G Ocln occludin decreases expression ISO Galactose results in decreased expression of OCLN protein CTD PMID:33516661 NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411 		JBrowse link
G Pdk1 pyruvate dehydrogenase kinase 1 multiple interactions ISO Galactose affects the reaction [Fusaric Acid results in increased expression of PDK1 protein] CTD PMID:31654802 NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:77,113,473...77,144,145 		JBrowse link
G Pkm pyruvate kinase M1/2 multiple interactions ISO Galactose affects the reaction [Fusaric Acid results in increased expression of PKM mRNA] CTD PMID:31654802 NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:68,948,815...68,975,396 		JBrowse link
G Plau plasminogen activator, urokinase increases expression
multiple interactions 		EXP Galactose results in increased expression of PLAU protein
Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of PLAU protein] 		CTD PMID:30367734 NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha decreases expression EXP Galactose results in decreased expression of PPARGC1A protein CTD PMID:28302704 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213 		JBrowse link
G Prdx2 peroxiredoxin 2 multiple interactions
decreases expression 		ISO theaflavin-3,3'-digallate inhibits the reaction [Galactose results in decreased expression of PRDX2 mRNA] CTD PMID:36638877 NCBI chr19:40,085,788...40,091,083
Ensembl chr19:40,084,430...40,091,006 		JBrowse link
G Psenen presenilin enhancer gamma secretase subunit multiple interactions
increases expression 		ISO gentiopicroside analog inhibits the reaction [Galactose results in increased expression of PSENEN protein] CTD PMID:36878094 NCBI chr 1:94,942,348...94,943,545
Ensembl chr 1:94,942,225...94,943,752 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression 		ISO Galactose results in increased expression of and results in increased activity of PTGS2 protein; lycopene inhibits the reaction [Galactose results in increased expression of PTGS2 mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of PTGS2 mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of PTGS2 protein] CTD PMID:22687555 PMID:28974442 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Rbpj recombination signal binding protein for immunoglobulin kappa J region multiple interactions ISO [Galactose co-treated with Aluminum Chloride] results in increased expression of RBPJ protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of RBPJ protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of RBPJ protein] CTD PMID:35537655 NCBI chr14:61,551,366...61,736,220
Ensembl chr14:61,551,366...61,736,307 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions
affects localization
increases expression 		ISO [Galactose co-treated with Aluminum Chloride] results in increased expression of and results in increased phosphorylation of RELA protein; [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] affects the localization of and results in increased expression of RELA protein; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of and results in increased phosphorylation of RELA protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of and results in increased phosphorylation of RELA protein]; Galactose results in increased expression of and results in increased activity of RELA protein; protocatechuic acid inhibits the reaction [Galactose results in increased expression of and results in increased activity of RELA protein]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of RELA mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of RELA protein]; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] affects the localization of and results in increased expression of RELA protein]; torularhodin inhibits the reaction [Galactose results in increased expression of RELA protein]; Vitamin E inhibits the reaction [Galactose results in increased expression of RELA protein]
ginsenoside F1 inhibits the reaction [Galactose affects the localization of RELA protein]; SB 203580 inhibits the reaction [Galactose affects the localization of RELA protein]
Galactose results in increased expression of RELA mRNA; Galactose results in increased expression of RELA protein 		CTD PMID:22687555 PMID:23535186 PMID:29412148 PMID:31431007 PMID:35537655 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Rest RE1-silencing transcription factor multiple interactions
decreases expression 		ISO gentiopicroside analog inhibits the reaction [Galactose results in decreased expression of REST protein] CTD PMID:36878094 NCBI chr14:31,213,415...31,233,451
Ensembl chr14:31,213,415...31,248,662 		JBrowse link
G Rnf31 ring finger protein 31 multiple interactions ISO [Lipopolysaccharides co-treated with Galactose] results in increased expression of RNF31 protein; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of GPT protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of IL6 protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNF protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNFAIP3 protein] CTD PMID:34416243 NCBI chr15:33,053,450...33,065,285
Ensembl chr15:33,053,607...33,065,284 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions
decreases expression 		EXP
ISO 		Saponins inhibits the reaction [Galactose results in decreased expression of SIRT1 protein]
[Glucose deficiency co-treated with Galactose co-treated with Amino Acids co-treated with Pyruvic Acid] inhibits the reaction [resveratrol results in increased expression of SIRT1 protein] 		CTD PMID:25892055 PMID:27358235 PMID:29426000 NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000 		JBrowse link
G Slc2a2 solute carrier family 2 member 2 increases transport ISO SLC2A2 protein results in increased transport of Galactose CTD PMID:8457197 NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:113,537,972...113,568,467 		JBrowse link
G Slc2a3 solute carrier family 2 member 3 increases transport
multiple interactions 		ISO SLC2A3 protein results in increased transport of Galactose
Galactose inhibits the reaction [SLC2A3 protein results in increased transport of Deoxyglucose]; Glucose inhibits the reaction [SLC2A3 protein results in increased transport of Galactose]; Maltose inhibits the reaction [SLC2A3 protein results in increased transport of Galactose] 		CTD PMID:8457197 NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:157,632,887...157,646,186 		JBrowse link
G Slc5a1 solute carrier family 5 member 1 multiple interactions
affects transport 		ISO Galactose inhibits the reaction [[Sodium co-treated with SLC5A1 protein] results in increased uptake of methylglucoside]
SLC5A1 protein affects the transport of Galactose 		CTD PMID:16300400 PMID:17288452 NCBI chr14:81,778,495...81,843,084
Ensembl chr14:81,778,348...81,846,624 		JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions
decreases expression 		ISO
EXP 		theaflavin-3,3'-digallate inhibits the reaction [Galactose results in decreased expression of SOD1 mRNA]
[Galactose co-treated with Finasteride] results in increased expression of SOD1 mRNA 		CTD PMID:36638877 PMID:39265715 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399 		JBrowse link
G Sod2 superoxide dismutase 2 decreases expression
multiple interactions 		EXP
ISO 		Galactose results in decreased expression of SOD2 mRNA
Saponins inhibits the reaction [Galactose results in decreased expression of SOD2 mRNA]
albicanol inhibits the reaction [Galactose results in decreased expression of SOD2 protein] 		CTD PMID:25892055 PMID:33761044 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Sord sorbitol dehydrogenase increases expression ISO Galactose results in increased expression of SORD mRNA CTD PMID:22687555 NCBI chr 3:129,638,282...129,669,727
Ensembl chr 3:129,638,302...129,686,100 		JBrowse link
G Sp1 Sp1 transcription factor multiple interactions
increases expression 		EXP Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of SP1 protein] CTD PMID:30367734 NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:135,420,050...135,450,513 		JBrowse link
G Sqstm1 sequestosome 1 multiple interactions
increases expression 		ISO
EXP 		Hydroxychloroquine inhibits the reaction [Metformin inhibits the reaction [Galactose results in increased expression of SQSTM1 protein]]; Metformin inhibits the reaction [Galactose results in increased expression of SQSTM1 protein]; MIR34A mRNA promotes the reaction [Galactose results in increased expression of SQSTM1 protein]
(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of SQSTM1 protein]; Chloroquine inhibits the reaction [(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose results in increased expression of SQSTM1 protein]] 		CTD PMID:28302704 PMID:29426000 PMID:36792013 NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750 		JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 increases expression ISO Galactose results in increased expression of SREBF1 mRNA CTD PMID:10913129 NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164 		JBrowse link
G Tfam transcription factor A, mitochondrial multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of TFAM protein CTD PMID:25997894 NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877 		JBrowse link
G Tfeb transcription factor EB multiple interactions
affects localization 		ISO (1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [Galactose affects the localization of TFEB protein] CTD PMID:36792013 NCBI chr 9:20,696,440...20,752,265
Ensembl chr 9:20,696,441...20,727,863 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
increases expression 		EXP Alpinia oxyphylla fruit extract inhibits the reaction [Galactose results in increased expression of TGFB1 protein] CTD PMID:30367734 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899 		JBrowse link
G Ticam1 TIR domain containing adaptor molecule 1 multiple interactions ISO
EXP 		[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TICAM1 protein; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TICAM1 protein]
[Galactose co-treated with Aluminum Chloride] results in increased expression of TICAM1 mRNA; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TICAM1 mRNA] 		CTD PMID:23535186 PMID:29405769 NCBI chr 9:1,189,717...1,197,730
Ensembl chr 9:1,172,963...1,196,892 		JBrowse link
G Tjp1 tight junction protein 1 decreases expression
multiple interactions 		ISO Galactose results in decreased expression of TJP1 protein
Ethanol promotes the reaction [Galactose results in decreased expression of TJP1 protein] 		CTD PMID:33516661 NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:128,260,330...128,505,158 		JBrowse link
G Tlr2 toll-like receptor 2 multiple interactions EXP [Galactose co-treated with Aluminum Chloride] results in increased expression of TLR2 mRNA; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TLR2 mRNA] CTD PMID:29405769 NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO
EXP 		[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TLR4 protein; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TLR4 protein]
[Galactose co-treated with Aluminum Chloride] results in increased expression of TLR4 mRNA; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TLR4 mRNA] 		CTD PMID:23535186 PMID:29405769 NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases secretion
increases expression 		ISO
EXP 		[Galactose co-treated with Aluminum Chloride] results in increased expression of TNF protein; [Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TNF protein; [Lipopolysaccharides co-treated with Galactose] results in increased expression of TNF protein; albicanol inhibits the reaction [Galactose results in increased expression of TNF mRNA]; astragalin inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TNF protein]; catalpol inhibits the reaction [Galactose results in increased expression of TNF protein]; Estradiol inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TNF protein]; Lycopene inhibits the reaction [Galactose results in increased expression of TNF protein]; protocatechuic acid inhibits the reaction [Galactose results in increased secretion of TNF protein]; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNF protein]; scoparone inhibits the reaction [[Galactose co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of TNF protein]
Galactose results in increased expression of TNF mRNA; Galactose results in increased expression of TNF protein
[Galactose co-treated with Aluminum Chloride] results in increased expression of TNF protein; candesartan inhibits the reaction [Galactose results in increased expression of TNF mRNA]; Galactose promotes the reaction [sodium arsenite results in increased expression of TNF mRNA]; thymoquinone inhibits the reaction [[Galactose co-treated with Aluminum Chloride] results in increased expression of TNF protein] 		CTD PMID:22687555 PMID:23535186 PMID:23612000 PMID:28974442 PMID:29405769 More... NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Tnfaip3 TNF alpha induced protein 3 multiple interactions ISO [Lipopolysaccharides co-treated with Galactose] results in increased expression of TNFAIP3 protein; RNF31 protein affects the reaction [[Lipopolysaccharides co-treated with Galactose] results in increased expression of TNFAIP3 protein] CTD PMID:34416243 NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979 		JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression 		ISO
EXP 		Phycocyanin inhibits the reaction [Galactose results in increased expression of TP53 protein]
[Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased expression of TP53 protein]; Finasteride inhibits the reaction [Galactose results in increased expression of TP53 protein] 		CTD PMID:23036742 PMID:25997894 PMID:29426000 PMID:39265715 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Txnip thioredoxin interacting protein multiple interactions
increases expression 		ISO Hydroxychloroquine inhibits the reaction [Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein]]; Metformin inhibits the reaction [Galactose results in increased expression of TXNIP protein] CTD PMID:29426000 NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731 		JBrowse link
G Txnrd1 thioredoxin reductase 1 decreases expression
multiple interactions 		ISO Galactose results in decreased expression of TXNRD1 mRNA
sodium bisulfide inhibits the reaction [Galactose results in decreased expression of TXNRD1 mRNA] 		CTD PMID:23274001 NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817 		JBrowse link
1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression ISO KRN 7000 results in increased expression of CXCL10 protein CTD PMID:15867097 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Il12b interleukin 12B increases expression ISO KRN 7000 results in increased expression of IL12B protein CTD PMID:15867097 NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194 		JBrowse link
alpha-D-galactose 1-phosphate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Galk1 galactokinase 1 multiple interactions ISO [Enzyme Inhibitors binds to and results in decreased activity of GALK1 protein] which results in decreased abundance of galactose-1-phosphate; [GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate CTD PMID:20696150 NCBI chr10:101,742,067...101,746,244
Ensembl chr10:101,735,061...101,746,258 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 20862
    role 20820
      biological role 20818
        biochemical role 20264
          metabolite 20245
            fundamental metabolite 14805
              galactose 229
                D-galactose 229
                  D-galactopyranose 229
                    alpha-D-galactose 121
                      1-O-(4-O-\{3-[4-(trifluoromethyl)phenyl]propyl\}-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                      1-O-(4-O-allyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                      1-O-(4-O-benzyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                      1-O-(4-O-propyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                      1-O-(6-acetamido-6-deoxy-alpha-D-galactosyl)-N-[(15Z)-tetracos-15-enoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(10-phenyldecanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(11-phenylundecanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(21-phenylhenicosanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(25-phenylpentacosanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(6-phenylhexanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(7-phenylheptanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(8-phenyloctanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-(9-phenylnonanoyl)phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[11-(4-fluorophenyl)undecanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[11-(4-methoxyphenyl)undecanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[6-(4-methoxyphenyl)hexanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[8-(4-fluorophenyl)octanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[8-(4-methoxyphenyl)octanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-[8-(4-trifluoromethyl)phenyloctanoyl]phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-\{11-[4-(trifluoromethyl)phenyl]undecanoyl\}phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-\{6-[4-(trifluoromethyl)phenyl]hexanoyl\}phytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-dodecanoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-hexacosanoylsphinganine 0
                      1-O-(alpha-D-galactopyranosyl)-N-icosa-11,14-dienoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-nonanoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-octanoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-pamitoylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-tetracosanyl-2-aminononane-1,3,4-triol 0
                      1-O-(alpha-D-galactopyranosyl)-N-tetracosanylphytosphingosine 0
                      1-O-(alpha-D-galactopyranosyl)-N-tetradecanoylphytosphingosine 0
                      1-O-(alpha-D-galactosyl)-N-decanoylphytosphingosine 0
                      1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine + 2
                      1-O-(alpha-D-galactosyl)-N-undecanoylphytosphingosine 0
                      1-O-[4-O-(2-adamantylethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(3,4-dichlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(3,4-difluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(3-phenylpropyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-chlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-fluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-methylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-phenylbutyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(4-tert-butylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(5-phenylpentyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(6-phenylhexyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(cyclobutylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[4-O-(cyclopropylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactopyranosyl]-N-hexacosanoylsphinganine 0
                      1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(3,4-dichlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-chlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-methoxyphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-methylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[3-(4-tert-butylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      1-O-\{4-O-[4-(trifluoromethyl)benzyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                      2-deoxy-2-fluoro-alpha-D-galactose 0
                      GlcpN-(1->1)-alpha-D-Galp 0
                      N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-11-phenylundecan-2-yl]hexacosanamide 0
                      N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-13-phenyltridecan-2-yl]hexacosanamide 0
                      N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-6-phenylhexan-2-yl]hexacosanamide 0
                      N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-8-phenyloctan-2-yl]hexacosanamide 0
                      N-[11-([1,1'-biphenyl]-4-yl)undecanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                      N-[6-(4-fluorophenyl)hexanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                      N-[6-([1,1'-biphenyl]-4-yl)hexanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                      N-[8-([1,1'-biphenyl]-4-yl)octanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                      alpha-D-Gal-(1->3)-alpha-D-Gal-OMe 0
                      alpha-D-Gal-(1->4)-alpha-D-Gal-OMe 0
                      alpha-D-Galf-(1->2)-alpha-D-Galp 0
                      alpha-D-Galp-(1->2)-alpha-D-Glcp 0
                      alpha-D-Galp-(1->2)-alpha-D-Manp 0
                      alpha-D-Galp-(1->2)-beta-D-Glcp-(1->4)-beta-D-Glcp 0
                      alpha-D-Galp-(1->2)-beta-D-Manp 0
                      alpha-D-Galp-(1->3)-D-GalNAc-OH 0
                      alpha-D-Galp-(1->3)-D-Glcp 0
                      alpha-D-Galp-(1->3)-alpha-D-GlcpNAc 0
                      alpha-D-Galp-(1->3)-alpha-D-Manp 0
                      alpha-D-Galp-(1->3)-beta-D-GlcpNAc + 0
                      alpha-D-Galp-(1->4)-D-Gal-OH 0
                      alpha-D-Galp-(1->4)-alpha-D-Glcp 0
                      alpha-D-Galp-(1->4)-alpha-L-Fucp 0
                      alpha-D-Galp-(1->4)-beta-D-Glcp + 0
                      alpha-D-Galp-(1->4)-beta-D-GlcpNAc 0
                      alpha-D-Galp-(1->6)-D-Glc-OH 0
                      alpha-D-Galp-(1->6)-alpha-D-Galp 0
                      alpha-D-Galp-(1->6)-alpha-D-Glcp 0
                      alpha-D-Galp-(1->6)-beta-D-Manp 0
                      alpha-D-GalpNAc-(1->3)-alpha-D-Galp + 0
                      alpha-D-Glcp-(1->3)-alpha-D-Galp + 0
                      alpha-D-Glcp-(1->6)-D-Gal-OH 0
                      alpha-D-Glcp-(1->6)-alpha-D-Galp + 0
                      alpha-D-GlcpN-(1->1)-alpha-D-Galp 0
                      alpha-D-Manp-(1->2)-alpha-D-Galp 0
                      alpha-D-galactose 1-phosphate 1
                      alpha-D-galactoside + 0
                      alpha-D-galactosyl group + 0
                      alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1<->1')-ceramide 0
                      alpha-L-Fucp-(1->2)-alpha-D-Galp 0
                      alpha-L-Fucp-(1->3)-alpha-D-Galp + 0
                      alpha-L-Fucp-(1->6)-alpha-D-Galp 0
                      beta-D-Galf-(1->3)-alpha-D-Galp 0
                      beta-D-Glcp-(1->3)-alpha-D-Galp 0
                      beta-D-Glcp-(1->6)-alpha-D-Galp 0
                      beta-D-GlcpNAc-(1->2-)alpha-D-Galp 0
                      beta-L-Fucp-(1->2)-alpha-D-Galp 0
                      beta-L-Fucp-(1->3)-alpha-D-Galp 0
                      beta-L-Fucp-(1->4)-alpha-D-Galp + 0
                      penta-O-acetyl-alpha-D-galactose 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 20862
    subatomic particle 20860
      composite particle 20860
        hadron 20860
          baryon 20860
            nucleon 20860
              atomic nucleus 20860
                atom 20860
                  main group element atom 20781
                    p-block element atom 20781
                      carbon group element atom 20715
                        carbon atom 20710
                          organic molecular entity 20710
                            heteroorganic entity 20219
                              organochalcogen compound 19904
                                organooxygen compound 19806
                                  carbohydrates and carbohydrate derivatives 15487
                                    carbohydrate 15487
                                      monosaccharide 5123
                                        aldose 3497
                                          aldohexose 3156
                                            D-aldohexose 3146
                                              D-galactose 229
                                                D-galactopyranose 229
                                                  alpha-D-galactose 121
                                                    1-O-(4-O-\{3-[4-(trifluoromethyl)phenyl]propyl\}-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                                                    1-O-(4-O-allyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                                                    1-O-(4-O-benzyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                                                    1-O-(4-O-propyl-alpha-D-galactosyl)-N-hexacosanoylphytosphingosine 0
                                                    1-O-(6-acetamido-6-deoxy-alpha-D-galactosyl)-N-[(15Z)-tetracos-15-enoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(10-phenyldecanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(11-phenylundecanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(21-phenylhenicosanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(25-phenylpentacosanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(6-phenylhexanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(7-phenylheptanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(8-phenyloctanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-(9-phenylnonanoyl)phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[11-(4-fluorophenyl)undecanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[11-(4-methoxyphenyl)undecanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[6-(4-methoxyphenyl)hexanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[8-(4-fluorophenyl)octanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[8-(4-methoxyphenyl)octanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-[8-(4-trifluoromethyl)phenyloctanoyl]phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-\{11-[4-(trifluoromethyl)phenyl]undecanoyl\}phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-\{6-[4-(trifluoromethyl)phenyl]hexanoyl\}phytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-dodecanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-hexacosanoylsphinganine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-icosa-11,14-dienoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-nonanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-octanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-pamitoylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-tetracosanyl-2-aminononane-1,3,4-triol 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-tetracosanylphytosphingosine 0
                                                    1-O-(alpha-D-galactopyranosyl)-N-tetradecanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactosyl)-N-decanoylphytosphingosine 0
                                                    1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine + 2
                                                    1-O-(alpha-D-galactosyl)-N-undecanoylphytosphingosine 0
                                                    1-O-[4-O-(2-adamantylethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(3,4-dichlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(3,4-difluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(3-phenylpropyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-chlorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-fluorobenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-methylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-phenylbutyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(4-tert-butylbenzyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(5-phenylpentyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(6-phenylhexyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(cyclobutylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[4-O-(cyclopropylmethyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactopyranosyl]-N-hexacosanoylsphinganine 0
                                                    1-O-[6-O-(3-phenylpropanoyl)-alpha-D-galactosyl]-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(3,4-dichlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-chlorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-fluorophenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-methoxyphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-methylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[3-(4-tert-butylphenyl)propyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    1-O-\{4-O-[4-(trifluoromethyl)benzyl]-alpha-D-galactosyl\}-N-hexacosanoylphytosphingosine 0
                                                    2-deoxy-2-fluoro-alpha-D-galactose 0
                                                    GlcpN-(1->1)-alpha-D-Galp 0
                                                    N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-11-phenylundecan-2-yl]hexacosanamide 0
                                                    N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-13-phenyltridecan-2-yl]hexacosanamide 0
                                                    N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-6-phenylhexan-2-yl]hexacosanamide 0
                                                    N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-8-phenyloctan-2-yl]hexacosanamide 0
                                                    N-[11-([1,1'-biphenyl]-4-yl)undecanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                                                    N-[6-(4-fluorophenyl)hexanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                                                    N-[6-([1,1'-biphenyl]-4-yl)hexanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                                                    N-[8-([1,1'-biphenyl]-4-yl)octanoyl]-1-O-(alpha-D-galactopyranosyl)phytosphingosine 0
                                                    alpha-D-Gal-(1->3)-alpha-D-Gal-OMe 0
                                                    alpha-D-Gal-(1->4)-alpha-D-Gal-OMe 0
                                                    alpha-D-Galf-(1->2)-alpha-D-Galp 0
                                                    alpha-D-Galp-(1->2)-alpha-D-Glcp 0
                                                    alpha-D-Galp-(1->2)-alpha-D-Manp 0
                                                    alpha-D-Galp-(1->2)-beta-D-Glcp-(1->4)-beta-D-Glcp 0
                                                    alpha-D-Galp-(1->2)-beta-D-Manp 0
                                                    alpha-D-Galp-(1->3)-D-GalNAc-OH 0
                                                    alpha-D-Galp-(1->3)-D-Glcp 0
                                                    alpha-D-Galp-(1->3)-alpha-D-GlcpNAc 0
                                                    alpha-D-Galp-(1->3)-alpha-D-Manp 0
                                                    alpha-D-Galp-(1->3)-beta-D-GlcpNAc + 0
                                                    alpha-D-Galp-(1->4)-D-Gal-OH 0
                                                    alpha-D-Galp-(1->4)-alpha-D-Glcp 0
                                                    alpha-D-Galp-(1->4)-alpha-L-Fucp 0
                                                    alpha-D-Galp-(1->4)-beta-D-Glcp + 0
                                                    alpha-D-Galp-(1->4)-beta-D-GlcpNAc 0
                                                    alpha-D-Galp-(1->6)-D-Glc-OH 0
                                                    alpha-D-Galp-(1->6)-alpha-D-Galp 0
                                                    alpha-D-Galp-(1->6)-alpha-D-Glcp 0
                                                    alpha-D-Galp-(1->6)-beta-D-Manp 0
                                                    alpha-D-GalpNAc-(1->3)-alpha-D-Galp + 0
                                                    alpha-D-Glcp-(1->3)-alpha-D-Galp + 0
                                                    alpha-D-Glcp-(1->6)-D-Gal-OH 0
                                                    alpha-D-Glcp-(1->6)-alpha-D-Galp + 0
                                                    alpha-D-GlcpN-(1->1)-alpha-D-Galp 0
                                                    alpha-D-Manp-(1->2)-alpha-D-Galp 0
                                                    alpha-D-galactose 1-phosphate 1
                                                    alpha-D-galactoside + 0
                                                    alpha-D-galactosyl group + 0
                                                    alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1<->1')-ceramide 0
                                                    alpha-L-Fucp-(1->2)-alpha-D-Galp 0
                                                    alpha-L-Fucp-(1->3)-alpha-D-Galp + 0
                                                    alpha-L-Fucp-(1->6)-alpha-D-Galp 0
                                                    beta-D-Galf-(1->3)-alpha-D-Galp 0
                                                    beta-D-Glcp-(1->3)-alpha-D-Galp 0
                                                    beta-D-Glcp-(1->6)-alpha-D-Galp 0
                                                    beta-D-GlcpNAc-(1->2-)alpha-D-Galp 0
                                                    beta-L-Fucp-(1->2)-alpha-D-Galp 0
                                                    beta-L-Fucp-(1->3)-alpha-D-Galp 0
                                                    beta-L-Fucp-(1->4)-alpha-D-Galp + 0
                                                    penta-O-acetyl-alpha-D-galactose 0
paths to the root